Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine and Tamoxifen in ALS
NCT01257581Phase 2Completed
- Start
- Mar 2011
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of creatine, tamoxifen in amyotrophic lateral sclerosis (ALS). Started Mar 2011; status: completed.
02
Drugs
creatinetamoxifen
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01257581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257581.